Personalized neoantigen vaccines in urologic malignancies

This publication has 15 references indexed in Scilit:

• A neoantigen vaccine generates antitumour immunity in renal cell carcinoma
  Nature, 2025
• Atezolizumab plus chemotherapy versus placebo plus chemotherapy in untreated locally advanced or metastatic urothelial carcinoma (IMvigor130): final overall survival analysis results from a randomised, controlled, phase 3 study
  The Lancet Oncology, 2023
• Cancer vaccines: Building a bridge over troubled waters
  Cell, 2022
• Deciphering the immunopeptidome in vivo reveals new tumour antigens
  Nature, 2022
• European Association of Urology Guidelines on Non–muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ)
  European Urology, 2022
• Clinical Utility of Cell-free and Circulating Tumor DNA in Kidney and Bladder Cancer: A Critical Review of Current Literature
  European Urology Oncology, 2021
• OpenVax: An Open-Source Computational Pipeline for Cancer Neoantigen Prediction
  2020
• Mechanisms of BCG immunotherapy and its outlook for bladder cancer
  Nature Reviews Urology, 2018
• Signatures of mutational processes in human cancer
  Nature, 2013
• A possible mechanism of intravesical BCG therapy for human bladder carcinoma: involvement of innate effector cells for the inhibition of tumor growth
  Cancer Immunology, Immunotherapy, 2009